Company Filing History:
Years Active: 2006-2009
Title: Heiko Tietgen: Innovator in Cancer Treatment
Introduction
Heiko Tietgen is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bengamide derivatives for cancer treatment. With a total of 2 patents, Tietgen's work is recognized for its potential impact on medical science.
Latest Patents
His latest patents focus on bengamide derivatives, which are formed during fermentation by the microorganism ST200611 (DSM 15898). These derivatives are aimed at treating cancer diseases and are incorporated into pharmaceuticals. The patents detail a process for preparing bengamides of a specific formula and highlight the use of the microorganism ST200611 in this innovative approach.
Career Highlights
Heiko Tietgen is currently associated with Sanofi-Aventis Deutschland GmbH, where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in the area of oncology.
Collaborations
Throughout his career, Tietgen has collaborated with notable colleagues such as Holger Hoffmann and Sabine Haag-Richter. These partnerships have contributed to the success of his research initiatives.
Conclusion
Heiko Tietgen's innovative work in developing bengamide derivatives showcases his commitment to advancing cancer treatment. His contributions to the pharmaceutical field are significant and hold promise for future medical advancements.